Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...

Guardant Health (NasdaqGS:GH) has launched the Shield Across America mobile screening tour to promote its FDA approved blood test for colorectal cancer. The tour is scheduled to reach more than 100 ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of Shield Across America, a historic coast-to-coast mobile screening tour bringing Shield, the ...

Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc. (NASDAQ:GH) completed the acquisition of the health technology company ...

Colorectal cancer is one of the cancers where, if found early, it has a 91% chance of survival for the patient. If you find ...

With colon cancer deaths rising among younger adults and millions of eligible Americans skipping their colonoscopies, Guardant Health is taking its Shield blood test on the road in hopes of tackling ...

Guardant Health is upping its game in the liquid biopsy space with the acquisition of MetaSight Diagnostics. The Redwood City, CA-based company doled out $59 million up front to a ...

Dr. McDreamy has signed onto yet another cancer awareness initiative. | Dr. McDreamy has signed onto yet another cancer awareness initiative. “Grey’s Anatomy” star Patrick Dempsey, who has worked with ...

US biotech company Guardant Health (Nasdaq: GH) has acquired Israeli precise liquid biopsy company MetaSight Diagnostics for an immediate payment of $59 million and an additional $90 million in ...

The Doctor Odyssey star, Joshua Jackson, spoke for the first time about the passing of his Dawson's Creek co-star, James Van Der Beek ...